BridgeMD
New treatment option for Neuromotor Dysphagia After Acute Stroke
Official title The Cooling Sensation Safe Deglution Study
ClinicalTrials.gov ID: NCT06936501
What this study is testing
- What it's testing
- Dysphagia is a common complication in patients who have suffered a cerebrovascular accident (CVA), with an incidence ranging from 29% to 81%. Rehabilitation improves dysphagia in 47% of cases within the first few weeks and in 17% within 2-4 months.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Men and women over 18 years old.
- Currently hospitalized due to an acute stroke.
- Confirmed diagnosis of dysphagia through V-VST (Volume-Viscosity Swallow Test).
- Ability to collaborate and respond to questionnaire questions and other research tools used in the study.
- Malnutrition or risk of malnutrition, requiring a thickened, high-calorie, high-protein ONS, as determined by medical assessment in routine clinical...
You likely can't join if
- Moderate to severe cognitive impairment that interferes with the correct interpretation of the study or its requirements.
- Diagnosis of advanced dementia, severe psychiatric illness, or any other central nervous system condition that impairs the patient's comprehension of...
- Sociocultural, linguistic, intellectual, or other factors that hinder the patient's proper understanding of the study.
- Diagnosis of galactosemia.
- Intolerance or refusal (for any reason) of oral nutritional supplements.
- Requirement for parenteral nutrition or contraindication to oral intake.
See the full eligibility criteria
- Men and women over 18 years old.
- Currently hospitalized due to an acute stroke.
- Confirmed diagnosis of dysphagia through V-VST (Volume-Viscosity Swallow Test).
- Ability to collaborate and respond to questionnaire questions and other research tools used in the study.
- Malnutrition or risk of malnutrition, requiring a thickened, high-calorie, high-protein ONS, as determined by medical assessment in routine clinical practice.
- Voluntary written informed consent to participate in the study.
- Moderate to severe cognitive impairment that interferes with the correct interpretation of the study or its requirements.
- Diagnosis of advanced dementia, severe psychiatric illness, or any other central nervous system condition that impairs the patient's comprehension of the study.
- Sociocultural, linguistic, intellectual, or other factors that hinder the patient's proper understanding of the study.
- Diagnosis of galactosemia.
- Intolerance or refusal (for any reason) of oral nutritional supplements.
- Requirement for parenteral nutrition or contraindication to oral intake.
- Severe active renal, hepatic, or gastrointestinal diseases that contraindicate the use of ONS
The study team makes the final eligibility decision.
Where it's taking place
- Málaga, Málaga, Spain
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Málaga, Málaga, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.